SGMT CIK: 1400118

Sagimet Biosciences Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY22
FY23
FY24
FY25
FY22 – FY25

Assets

(positive)
Change from FY22 to FY25
millions USD
FY22:
32.8
FY23:
96.6
FY24:
153
FY25:
116
(positive)
Change from FY22 to FY25
millions USD
FY22:
0.24
FY23:
0.07
FY24:
7.49
FY25:
0.08
Total assets
Change from FY22 to FY25
millions USD
FY22:
33.0
FY23:
96.7
FY24:
160
FY25:
116

Liabilities & Equity

(negative)
Change from FY22 to FY25
millions USD
FY22:
5.28
FY23:
5.65
FY24:
4.45
FY25:
5.10
(negative)
Change from FY22 to FY25
millions USD
FY22:
0.08
FY23:
0
FY24:
0
FY25:
0
(positive)
Change from FY22 to FY25
millions USD
FY22:
−187
FY23:
91.1
FY24:
156
FY25:
111
Total liabilities & equity
Change from FY23 to FY25
millions USD
FY22:
–
FY23:
96.7
FY24:
160
FY25:
116

All amounts in millions USD Data sources:SEC EDGARTwelve Data